Berlin, Germany

Georg Ro/ Ssling

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Georg Roßling: Innovator in Ultrasonic Contrast Media

Introduction

Georg Roßling is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical imaging, particularly in the development of ultrasonic contrast media. His innovative work has led to the creation of a patented technology that enhances the effectiveness of ultrasound diagnostics.

Latest Patents

Roßling holds a patent for "Contrast media synthesized from polyaldehydes." This invention involves microparticles made from biodegradable polymers, which are synthesized from polymerizable aldehydes. These microparticles may include additives, crosslinkers, surfactants, and other components that enhance their suitability as ultrasonic contrast media. The patent highlights the potential for these materials to improve diagnostic imaging techniques.

Career Highlights

Throughout his career, Georg Roßling has been associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical and healthcare sector. His work at Schering has allowed him to focus on innovative solutions in medical imaging, contributing to advancements in patient care and diagnostic accuracy.

Collaborations

Roßling has collaborated with several talented individuals in his field, including Celal Albayrak and Matthias Rothe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Georg Roßling's contributions to the field of ultrasonic contrast media exemplify the impact of innovation in medical technology. His patented work continues to influence the way ultrasound diagnostics are performed, ultimately benefiting patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…